Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Applied Therapeutics stock
Learn how to easily invest in Applied Therapeutics stock.
Applied Therapeutics Inc is a biotechnology business based in the US. Applied Therapeutics shares (APLT) are listed on the NASDAQ and all prices are listed in US Dollars. Applied Therapeutics employs 27 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in Applied Therapeutics
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – APLT – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Applied Therapeutics stock price (NASDAQ: APLT)Use our graph to track the performance of APLT stocks over time.
Applied Therapeutics shares at a glance
|Latest market close||$3.31|
|52-week range||$2.88 - $29.80|
|50-day moving average||$9.01|
|200-day moving average||$15.56|
|Wall St. target price||$31.83|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-4.14|
Buy Applied Therapeutics shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Applied Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Applied Therapeutics price performance over time
|1 week (2022-01-19)||-7.54%|
|1 month (2021-12-23)||-66.36%|
|3 months (2021-10-26)||-78.34%|
|6 months (2021-07-26)||-81.81%|
|1 year (2021-01-26)||-83.89%|
|2 years (2020-01-24)||-93.20%|
|3 years (2019-01-22)||N/A|
|5 years (2017-01-22)||N/A|
Applied Therapeutics financials
|Gross profit TTM||$0|
|Return on assets TTM||-52.52%|
|Return on equity TTM||-107.69%|
|Market capitalisation||$83.1 million|
TTM: trailing 12 months
Applied Therapeutics share dividends
We're not expecting Applied Therapeutics to pay a dividend over the next 12 months.
Applied Therapeutics share price volatility
Over the last 12 months, Applied Therapeutics's shares have ranged in value from as little as $2.88 up to $29.8. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Applied Therapeutics's is 0.9037. This would suggest that Applied Therapeutics's shares are less volatile than average (for this exchange).
Applied Therapeutics overview
Applied Therapeutics, Inc. , a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase I/II for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study for the treatment of galactosemia in kids; for treating sorbitol dehydrogenase deficiency; and for the treatment of phosphomannomutase enzyme-CDG. The company also develops AT-001 that is in phase III clinical trials for treating diabetic cardiomyopathy, as well as for the treatment of diabetic peripheral neuropathy. Its preclinical stage products include AT-003 for the treatment diabetic retinopathy; AT-104, a PI3K inhibitor for treating orphan hematological oncology T Cell Acute Lymphoblastic Leukemia. Applied Therapeutics, Inc. was incorporated in 2016 and is headquartered in New York, New York.
Applied Therapeutics in the news
APPLIED THERAPEUTICS INC. : Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits (form 8-K)
Netflix shares fall near pre-pandemic level as investors fear slowing subscriber growth, competition
Stocks making the biggest moves midday: Netflix, Kohl's, Wynn Resorts, General Motors and more
Frequently asked questionsWhat percentage of Applied Therapeutics is owned by insiders or institutions?
Currently 21.419% of Applied Therapeutics shares are held by insiders and 78.431% by institutions. How many people work for Applied Therapeutics?
Latest data suggests 27 work at Applied Therapeutics. When does the fiscal year end for Applied Therapeutics?
Applied Therapeutics's fiscal year ends in December. Where is Applied Therapeutics based?
Applied Therapeutics's address is: 545 Fifth Avenue, New York, NY, United States, 10017 What is Applied Therapeutics's ISIN number?
Applied Therapeutics's international securities identification number is: US03828A1016 What is Applied Therapeutics's CUSIP number?
Applied Therapeutics's Committee on Uniform Securities Identification Procedures number is: 03828A101
More guides on Finder
Walmart dives deep into the metaverse with crypto and NFTs
Walmart files trademarks with the goal to issue its own cryptocurrency and NFTs for use in its digital stores.
Melania Trump has an NFT — what to know before you buy
Melania Trump launched an NFT platform — you can buy an image of her eyes.
Vigorus (VIS) price prediction
Read our expert analysis on Vigorus and how the token will perform in the future.
Today’s top U.S. stocks: Mechel Pao ADRs (MTL ↑8.1%), Sibanye-Stillwater Limited (SBSW ↑7.4%)
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
How to order free at-home COVID tests today — but note, there’s a wait
Starting Jan. 18, every household can order up to four free at-home COVID-19 tests. But you’ll have to wait for them.
Today’s top U.S. stocks: Las Vegas Sands (LVS ↑15.3%), Wynn Resorts Limited (WYNN ↑9.1%)
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Donut savings review
Donut earns up to 10% APY, but you must have an iOS device.
Monie savings review
Monie offers 5% APY on deposits, but funds aren’t insured and the interface is buggy.
Covid test stocks
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Is Berkshire Hathaway the next $1 trillion stock?
Buffett’s Berkshire Hathaway may now be on its way to becoming the next trillion-dollar company.
Ask an Expert